References
- Binet J L, Augueir A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukaemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
- Juliusson G, Johnson S AN, Christiansen I, et al. Oral 2-chlorodeoxyadenosine (CdA) as primary treatment for symptomatic chronic lymphocytic leukaemia (CLL). Proc Am Soc Haematol, Missouri 1993
- Cheson B D, Bennett J M, Rai K R, et al. Guidelines for clinical protocols for chronic lymphocytic leukaemia: recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 1988; 29: 152–63
- International Workshop on Chronic Lymphocytic Leukaemia. Chronic lymphocytic leukaemia: recommendations for diagnosis, staging and response criteria. Ann Intern Med 1989; 110: 236–8
- Letwin B W, Wallace P K, Muirhead K A, Hensler G L, Kashatus W H, Horan P K. An improved clonal excess assay using flow cytometry and B-cell gating. Blood 1990; 75: 1178–85
- Johnson A, Olafsson T. Flow cytometric clonal excess analysis of peripheral blood, routine handling and pitfalls in interpretation. Cytometry 1993; 14: 188–95
- Wan J H, Trainor K J, Brisco M J, Morley A A. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990; 43: 888–90
- Pollard P, Owen G, Worwood M. PCR based immunogeno-typing at the Ig heavy chain CDR 3 locus: improvements in resolution. Br J Haematol 1993; 84: 169–71
- Deane M, Hoffbrand A V. Detection of minimal residual disease in ALL. In: Leukaemia: advances research and treatment. Kluwer Academic Publishers, Dordrecht 1993; 142–55
- Richardson D S, Johnson S A, Hopkins J A, Howe D, Phillips M J. Absence of minimal residual disease detectable by FACS, Southern blot or PCR in patients with chronic lymphocytic leukaemia treated with fludarabine. Acta Oncol 1994; 33: 627–30
- Saven A, Carrera C J, Carson D A, Beutler E, Piro D L. 2-chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukaemia. Leuk Lymphoma 1991; 5((Suppl))133–8
- Juliusson G, Elmhorn-Rosenborg A, Liliemark J. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukaemia resistant to fludarabine. N Engl J Med 1992; 327: 1056–61
- Juliusson G, Liliemark J. High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukaemia: response predicted by rapid decrease of blood lymphocyte count. J Clin Oncol 1993; 11: 679–89
- Juliusson G, Liliemark J. Complete remission of B-cell chronic lymphocytic leukaemia after oral cladribine. Lancet 1993; 341: 54